Clinical Trial Update: Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial examining radioligand therapy after PSMA PET-guided external beam radiotherapy for post-prostatectomy patients with biochemically recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Radioligand Therapy

Snippet

Sponsor: Emory University | Conditions: Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING